PRLD - Prelude Therapeutics Inc

QQQ $ 446.25 $ -12.35 (-2.68 %)

DIA $ 404.28 $ -3.99 (-0.98 %)

SPY $ 539.90 $ -9.25 (-1.68 %)

TLT $ 99.49 $ -0.01 (-0.01 %)

GLD $ 230.65 $ -1.72 (-0.74 %)

Previous Close

$ 4.85

Open

Bid

$ 4.70 x 137

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 1.66 - $ 6.80

Volume

215,581

Average Volume

Market Cap

266.87M

Beta (5Y Monthly)

$ 1.50

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-12-2024	06-30-2024	10-Q
2	05-07-2024	03-31-2024	10-Q
3	02-15-2024	12-31-2023	10-K
4	11-01-2023	09-30-2023	10-Q
5	08-03-2023	06-30-2023	10-Q
6	05-08-2023	03-31-2023	10-Q
7	03-15-2023	12-31-2022	10-K
8	11-14-2022	09-30-2022	10-Q
9	08-09-2022	06-30-2022	10-Q
10	05-10-2022	03-31-2022	10-Q
11	03-17-2022	12-31-2021	10-K
12	11-12-2021	09-30-2021	10-Q
13	08-12-2021	06-30-2021	10-Q
14	05-11-2021	03-31-2021	10-Q
15	03-16-2021	12-31-2020	10-K
16	11-10-2020	09-30-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Neutral on ...
08/15/2024 10:36:29

HC Wainwright & Co. analyst Robert Burns reiterates Prelude Therapeutics (NASDAQ:PRLD) with a Neutral and maintains $5 p...

ubs-posts-upbeat-earnings-joins-victorias-secret-performance-food-group-kellanova-and-other-big-stocks-moving-higher-on-wednesday

UBS Posts Upbeat Earnings, Joins Victoria'...
08/14/2024 14:36:17

Prelude Therapeutics Q2 2024 GAAP EPS $(0....
08/12/2024 11:05:20

Prelude Therapeutics (NASDAQ:PRLD) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate o...

Prelude Therapeutics Collaborates With Mer...
07/09/2024 11:34:54

Combining a first-in-class, highly selective SMARCA2 degrader with an anti-PD-1 therapy may potentially enhance the anti-tumor ...

Prelude Therapeutics Disclosed Laurent Cha...
04/10/2024 20:11:07

-SEC Filing

JMP Securities Initiates Coverage On Prelu...
03/13/2024 09:20:21

JMP Securities analyst Reni Benjamin initiates coverage on Prelude Therapeutics (NASDAQ:PRLD) with a Market Outperform ratin...

HC Wainwright & Co. Downgrades Prelude The...
02/20/2024 14:03:38

HC Wainwright & Co. analyst Robert Burns downgrades Prelude Therapeutics (NASDAQ:PRLD) from Buy to Neutral and announces...

12-health-care-stocks-moving-in-fridays-intraday-session

12 Health Care Stocks Moving In Friday's I...
02/16/2024 17:31:13

Prelude Therapeutics Reports FY23 Financia...
02/15/2024 21:40:04

First-in-class IV SMARCA2 degrader and potentially best-in-class CDK9 inhibitor on track to generate potential proof-of-concept...

Morgan Stanley Downgrades Prelude Therapeu...
12/19/2023 17:00:25

Morgan Stanley Downgrades Prelude Therapeu...
12/19/2023 14:33:08

Morgan Stanley analyst Jeffrey Hung downgrades Prelude Therapeutics (NASDAQ:PRLD) from Equal-Weight to Underweight and lower...

Prelude Therapeutics Entered Into A Securi...
12/11/2023 14:24:19

On December 11, 2023, Prelude Therapeutics Incorporated, a Delaware corporation (the "Company"), entered into a securit...

HC Wainwright & Co. Maintains Buy on Prelu...
11/07/2023 18:20:28

HC Wainwright & Co. analyst Robert Burns maintains Prelude Therapeutics (NASDAQ:PRLD) with a Buy and lowers the price ta...

Prelude Therapeutics Q3 EPS $(0.45) Beats ...
11/01/2023 21:50:54

Prelude Therapeutics (NASDAQ:PRLD) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of ...

Prelude Therapeutics And AbCellera Enter P...
11/01/2023 21:18:40

Prelude Therapeutics Incorporated ("Prelude") (NASDAQ:PRLD) and AbCellera (NASDAQ:ABCL) today announced a multi-year, m...

Best Buy To Rally More Than 21%? Here Are ...
10/19/2023 12:03:18

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

The Latest Analyst Ratings for Prelude The...
10/19/2023 12:00:42

HC Wainwright & Co. Maintains Buy on Prelu...
10/19/2023 11:06:24

HC Wainwright & Co. analyst Robert Burns maintains Prelude Therapeutics (NASDAQ:PRLD) with a Buy and lowers the price ta...

Stocks That Hit 52-Week Lows On Tuesday
10/10/2023 17:09:29

Tuesday saw 132 companies set new 52-week lows.

Stocks That Hit 52-Week Lows On Friday
09/15/2023 15:52:24

Friday's session saw 169 companies set new 52-week lows.